{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:23:54Z","timestamp":1789874634554,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Frequent serial monitoring of plasma cytomegalovirus (CMV) viral load caused unnecessary budgets for laboratory testing without changes in treatment. We aimed to implement diagnostic stewardship to limit CMV viral load testing at appropriate intervals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A quasi-experimental study was performed. To avoid unnecessary plasma CMV viral load testing, the inpatient electronic pop-up reminder was launched in 2021. In cases with plasma CMV viral load testing was ordered in intervals of less than five days, telephone interview and feedback were performed. Pre-post intervention data was compared in terms of clinical and monetary outcomes. The rate of plasma CMV viral load testing performed in intervals of less than five days was compared between 2021 and 2019 using the Poisson regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After the protocol implementation, there was a significant decrease in the rate of plasma CMV viral load test orders in intervals of less than five days from 17.5% to 8.0% [incidence rate ratio 0.40, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001]. There was no statistically significant difference in the incidence of CMV DNAemia and CMV disease (<jats:italic>p<\/jats:italic>\u2009=\u20090.407 and 0.602, respectively). As a result, the hospital could save the costs of plasma CMV viral load testing per 1,000 patients performed with intervals of less than five days from 2,646,048.11 to 1,360,062.89 Thai Baht.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The diagnostic stewardship program is safe and helpful in reducing unnecessary plasma CMV viral load testing and costs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08355-0","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T09:02:17Z","timestamp":1686301337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic stewardship to limit repeat plasma cytomegalovirus viral load testing"],"prefix":"10.1186","volume":"23","author":[{"given":"Akeatit","family":"Trirattanapikul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekawat","family":"Pasomsub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Siriyotha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oraluck","family":"Pattanaprateep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angsana","family":"Phuphuakrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"8355_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12594","volume":"20","author":"C Lumbreras","year":"2014","unstructured":"Lumbreras C, Manuel O, Len O, ten Berge IJM, Sgarabotto D, Hirsch HH. Cytomegalovirus infection in solid organ transplant recipients. Clin Microbiol Infect. 2014;20:19\u201326.","journal-title":"Clin Microbiol Infect"},{"key":"8355_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","volume":"22","author":"U Sahin","year":"2016","unstructured":"Sahin U, Toprak SK, Atilla PA, Atilla E, Demirer T. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016;22:505\u201314.","journal-title":"J Infect Chemother"},{"key":"8355_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00296-019-04324-6","volume":"39","author":"BJ Gardiner","year":"2019","unstructured":"Gardiner BJ, Haas EM, Bailey RC, Chow JK, Snydman DR. Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case\u2013control study. Rheumatol Int. 2019;39:1229\u201340.","journal-title":"Rheumatol Int"},{"key":"8355_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10156-003-0251-9","volume":"9","author":"A Manna","year":"2003","unstructured":"Manna A, Pronzato P, Cordani S, Canessa P. CMV infection and pneumonia in hematological malignancies. J Infect Chemother. 2003;9:265\u20137.","journal-title":"J Infect Chemother"},{"key":"8355_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fmed.2020.00188","volume":"7","author":"J Schildermans","year":"2020","unstructured":"Schildermans J, De Vlieger G. Cytomegalovirus: a troll in the ICU? Overview of the literature and perspectives for the future. Front Med. 2020;7:188.","journal-title":"Front Med"},{"key":"8355_CR6","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.transproceed.2011.05.007","volume":"43","author":"L Linares","year":"2011","unstructured":"Linares L, Sanclemente G, Cervera C, Hoyo I, Cof\u00e1n F, Ricart MJ, et al. Influence of cytomegalovirus disease in outcome of solid organ transplant patients. Transplant Proc. 2011;43:2145\u20138.","journal-title":"Transplant Proc"},{"key":"8355_CR7","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","volume":"127","author":"P Teira","year":"2016","unstructured":"Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127:2427\u201338.","journal-title":"Blood"},{"key":"8355_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.blre.2017.01.002","volume":"31","author":"ST Chan","year":"2017","unstructured":"Chan ST, Logan AC. The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: why the quest for meaningful prophylaxis still matters. Blood Rev. 2017;31:173\u201383.","journal-title":"Blood Rev"},{"key":"8355_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102:900\u201331.","journal-title":"Transplantation"},{"key":"8355_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/cid\/cix793","volume":"66","author":"Y Natori","year":"2018","unstructured":"Natori Y, Alghamdi A, Tazari M, Miller V, Husain S, Komatsu T, et al. Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis. Clin Infect Dis. 2018;66:617\u201331.","journal-title":"Clin Infect Dis"},{"key":"8355_CR11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/cid\/cis212","volume":"54","author":"CS Kraft","year":"2012","unstructured":"Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis. 2012;54:1793\u20137.","journal-title":"Clin Infect Dis"},{"key":"8355_CR12","unstructured":"U. S. Food and Drug Administration. Nucleic acid based tests. FDA. 2022. https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/nucleic-acid-based-tests. Accessed 19 Jul 2022."},{"key":"8355_CR13","unstructured":"Fryer JF, Heath AB, Anderson R, Minor PD, Unit WHOB, Group CS, et al. Collaborative study to evaluate the proposed first WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. World Health Organization; 2010."},{"key":"8355_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jviromet.2015.08.010","volume":"225","author":"M-A Tremblay","year":"2015","unstructured":"Tremblay M-A, Rodrigue M-A, Desch\u00eanes L, Boivin G, Longtin J. Cytomegalovirus quantification in plasma with abbott realtime CMV and roche cobas amplicor CMV assays. J Virol Methods. 2015;225:1\u20133.","journal-title":"J Virol Methods"},{"key":"8355_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/cid\/ciw370","volume":"63","author":"JK Preiksaitis","year":"2016","unstructured":"Preiksaitis JK, Hayden RT, Tong Y, Pang XL, Fryer JF, Heath AB, et al. Are we there yet? Impact of the First International Standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples. Clin Infect Dis. 2016;63:583\u20139.","journal-title":"Clin Infect Dis"},{"key":"8355_CR16","first-page":"204993612095956","volume":"7","author":"M O\u2019Neal","year":"2020","unstructured":"O\u2019Neal M, Murray H, Dash S, Al-Hasan MN, Justo JA, Bookstaver PB. Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system. Ther Adv Infect Dis. 2020;7:204993612095956.","journal-title":"Ther Adv Infect Dis"},{"key":"8355_CR17","doi-asserted-by":"publisher","first-page":"e00311","DOI":"10.1128\/JCM.00311-20","volume":"58","author":"MJ Broadhurst","year":"2020","unstructured":"Broadhurst MJ, Dujari S, Budvytiene I, Pinsky BA, Gold CA, Banaei N. Utilization, yield, and accuracy of the filmarray meningitis\/encephalitis panel with diagnostic stewardship and testing algorithm. J Clin Microbiol. 2020;58:e00311-e320.","journal-title":"J Clin Microbiol"},{"key":"8355_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/ice.2020.375","volume":"42","author":"D Solanky","year":"2021","unstructured":"Solanky D, Juang DK, Johns ST, Drobish IC, Mehta SR, Kumaraswamy M. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset clostridioides difficile infection. Infect Control Hosp Epidemiol. 2021;42:51\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8355_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1017\/ice.2020.12","volume":"41","author":"JR Howard-Anderson","year":"2020","unstructured":"Howard-Anderson JR, Sexton ME, Robichaux C, Wiley Z, Varkey JB, Suchindran S, et al. The impact of an electronic medical record nudge on reducing testing for hospital-onset Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2020;41:411\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8355_CR20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1086\/339329","volume":"34","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094\u20137.","journal-title":"Clin Infect Dis"},{"key":"8355_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","volume":"6","author":"A Humar","year":"2006","unstructured":"Humar A, Michaels M, on behalf of the AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant. 2006;6:262\u201374.","journal-title":"Am J Transplant"},{"key":"8355_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.12659\/AOT.915168","volume":"24","author":"GR Madden","year":"2019","unstructured":"Madden GR, Sifri CD. Reduced Clostridioides difficile tests among solid organ transplant recipients through a diagnostic stewardship bundled intervention. Ann Transplant. 2019;24:304\u201311.","journal-title":"Ann Transplant"},{"key":"8355_CR23","doi-asserted-by":"publisher","first-page":"ofaa366","DOI":"10.1093\/ofid\/ofaa366","volume":"7","author":"C Liu","year":"2020","unstructured":"Liu C, Lan K, Krantz EM, Kim HN, Zier J, Bryson-Cahn C, et al. Improving appropriate diagnosis of Clostridioides difficile infection through an enteric pathogen order set with computerized clinical decision support: an interrupted time series analysis. Open Forum Infect Dis. 2020;7:ofaa366.","journal-title":"Open Forum Infect Dis"},{"key":"8355_CR24","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","volume":"19","author":"P Ljungman","year":"2019","unstructured":"Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, et al. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19:e260-72.","journal-title":"Lancet Infect Dis"},{"key":"8355_CR25","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","volume":"118","author":"F Milano","year":"2011","unstructured":"Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, et al. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood. 2011;118:5689\u201396.","journal-title":"Blood"},{"key":"8355_CR26","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.bbmt.2018.05.008","volume":"24","author":"JA Hill","year":"2018","unstructured":"Hill JA, Pergam SA, Cox E, Xie H, Leisenring WM, Boeckh M, et al. A modified intensive strategy to prevent cytomegalovirus disease in seropositive umbilical cord blood transplantation recipients. Biol Blood Marrow Transplant. 2018;24:2094\u2013100.","journal-title":"Biol Blood Marrow Transplant"},{"key":"8355_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s12185-010-0597-6","volume":"91","author":"M Schmidt-Hieber","year":"2010","unstructured":"Schmidt-Hieber M, Schwarck S, Stroux A, Ganepola S, Reinke P, Thiel E, et al. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion. Int J Hematol. 2010;91:877\u201385.","journal-title":"Int J Hematol"},{"key":"8355_CR28","first-page":"6551","volume":"37","author":"M Dziedzic","year":"2017","unstructured":"Dziedzic M, Sadowska-Krawczenko I, Styczynski J. Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification. Anticancer Res. 2017;37:6551.","journal-title":"Anticancer Res"},{"key":"8355_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","volume":"7","author":"J Styczynski","year":"2018","unstructured":"Styczynski J. Who is the patient at risk of CMV Recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018;7:1\u201316.","journal-title":"Infect Dis Ther"},{"key":"8355_CR30","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1080\/10428194.2020.1747067","volume":"61","author":"L Mountjoy","year":"2020","unstructured":"Mountjoy L, Jain T, Kunze KL, Khera N, Sproat LZ, Jennifer W, et al. Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2020;61:1996\u20132002.","journal-title":"Leuk Lymphoma"},{"key":"8355_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42358-019-0055-y","volume":"59","author":"HMC Choo","year":"2019","unstructured":"Choo HMC, Cher WQ, Kwan YH, Fong WWS. Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Adv Rheumatol. 2019;59:12.","journal-title":"Adv Rheumatol"},{"key":"8355_CR32","unstructured":"Abstract: Risk factors of cytomegalovirus disease among patients with systemic lupus erythematosus (IDWeek 2013 poster abstract session). https:\/\/idsa.confex.com\/idsa\/2013\/webprogram\/Paper40261.html. Accessed 2 Nov 2022."},{"key":"8355_CR33","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/cc7875","volume":"13","author":"R Osawa","year":"2009","unstructured":"Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13:R68.","journal-title":"Crit Care"},{"key":"8355_CR34","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1097\/IPC.0000000000001035","volume":"29","author":"L Amundson","year":"2021","unstructured":"Amundson L, Boelts B, Kataria V, Spak C. Ganciclovir therapy for CMV viremia in a patient on VV ECMO with COVID-19 after treatment with tocilizumab. Infect Dis Clin Pract. 2021;29:e191\u20132.","journal-title":"Infect Dis Clin Pract"},{"key":"8355_CR35","doi-asserted-by":"publisher","first-page":"e13455","DOI":"10.1111\/tid.13455","volume":"23","author":"H Molaei","year":"2021","unstructured":"Molaei H, Khedmat L, Nemati E, Rostami Z, Saadat SH. Iranian kidney transplant recipients with COVID-19 infection: clinical outcomes and cytomegalovirus coinfection. Transpl Infect Dis. 2021;23:e13455.","journal-title":"Transpl Infect Dis"},{"key":"8355_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/tropicalmed6010022","volume":"6","author":"SC Gozzi-Silva","year":"2021","unstructured":"Gozzi-Silva SC, Benard G, Alberca RW, Yendo TM, Teixeira FME, de Oliveira LM, et al. SARS-CoV-2 infection and CMV dissemination in transplant recipients as a treatment for Chagas cardiomyopathy: a case report. Trop Med Infect Dis. 2021;6:22.","journal-title":"Trop Med Infect Dis"},{"key":"8355_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.11604\/pamj.2020.36.167.23922","volume":"36","author":"S Oualim","year":"2020","unstructured":"Oualim S, Elouarradi A, Hafid S, Naitelhou A, Sabry M. A misleading CMV myocarditis during the COVID-19 pandemic: case report. Pan Afr Med J. 2020;36:167.","journal-title":"Pan Afr Med J"},{"key":"8355_CR38","doi-asserted-by":"publisher","first-page":"e00801","DOI":"10.1002\/rcr2.801","volume":"9","author":"S Amiya","year":"2021","unstructured":"Amiya S, Hirata H, Shiroyama T, Adachi Y, Niitsu T, Noda Y, et al. Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19. Respirol Case Rep. 2021;9:e00801.","journal-title":"Respirol Case Rep"},{"key":"8355_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/covid1010010","volume":"1","author":"AS Shaikh","year":"2021","unstructured":"Shaikh AS, Shaim H, Caravedo MA, Ong KM, Reynoso D. A new viral coinfection: SARS-CoV-2 pneumonia and cytomegalovirus pneumonitis in a renal transplant recipient. COVID. 2021;1:115\u20139.","journal-title":"COVID"},{"key":"8355_CR40","doi-asserted-by":"publisher","first-page":"e01111","DOI":"10.1016\/j.idcr.2021.e01111","volume":"24","author":"F Maillet","year":"2021","unstructured":"Maillet F, Pourbaix A, le Pluart D, Sirmai L, Postolache SA, Couvelard A, et al. Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments. IDCases. 2021;24:e01111.","journal-title":"IDCases"},{"key":"8355_CR41","doi-asserted-by":"publisher","first-page":"e13586","DOI":"10.1111\/tid.13586","volume":"23","author":"MR Jorgenson","year":"2021","unstructured":"Jorgenson MR, Descourouez JL, Wong C, Strayer JR, Parajuli S, Rice JP, et al. Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies. Transpl Infect Dis. 2021;23:e13586.","journal-title":"Transpl Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08355-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T09:03:50Z","timestamp":1686301430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8355"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08355-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<i>This study was performed in line with the principles of the Declaration of Helsinki.<\/i> The study was approved by Human Research Ethics Committee, Faculty of Medicine Ramathibodi Hospital Mahidol University, approval number MURA 2021\/12.The informed consent was obtained from the interviewed physicians as the decision for test ordering depended on the physician.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"387"}}